Compare · CUVL vs NEWA
CUVL vs NEWA
Side-by-side comparison of Clinuvel Pharmaceuticals Limited (CUVL) and Newater Technology, Inc. (NEWA): market cap, price performance, sector, and recent activity on the wire.
Summary
- CUVL operates in Industrials, while NEWA operates in Basic Materials - the two are in different parts of the market.
- CUVL carries a market cap of $254.7M.
- Company
- Clinuvel Pharmaceuticals Limited
- Newater Technology, Inc.
- Price
- -
- -
- Market cap
- $254.7M
- -
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Miscellaneous
- Miscellaneous
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2017
- News (4w)
- 0
- 0
- Recent ratings
- 0
- 0
CUVL
Clinuvel Pharmaceuticals Limited
CLINUVEL is a global biopharmaceutical company focused on developing and delivering innovative therapies for patients with genetic, metabolic, and dermatological disorders. The Company's portfolio is centred around melanocortin peptides, with programs advancing in photomedicine and vitiligo. CLINUVEL is listed on the Australian Securities Exchange (ASX: CUV) and the Nasdaq Stock Market (Nasdaq: CUVL).
Latest CUVL
No recent items for Clinuvel Pharmaceuticals Limited.
Latest NEWA
- Barrick Gold Reports Investment In Tanzania
- SEC Form 15-12B filed by Newater Technology, Inc.
- SEC Form SC 13E3/A filed by Newater Technology, Inc. (Amendment)
- SEC Form 6-K filed by Newater Technology, Inc.
- Newater Technology, Inc. Announces Completion of Merger
- SEC Form 25-NSE filed by Newater Technology, Inc.
- SEC Form 6-K filed by Newater Technology, Inc.
- Newater Technology, Inc. Announces Shareholders' Approval of Merger Agreement
- SEC Form SC 13E3/A filed by Newater Technology, Inc. (Amendment)
- SEC Form 6-K filed by Newater Technology, Inc.